🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to investigate the pharmacokinetics of single ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-12
Trial ID
NCT01250730
Treatments Being Tested
This is an open label expanded access protocol for the treatment of up to a...
Status
No Longer Available
Location
Children's Hospital Colorado
Start Date
TBD
Trial ID
NCT02473497
Treatments Being Tested
A phase 3 study to evaluate the efficacy and safety of SY-3505 vs. crizotin...
Status
Not Yet Recruiting
Location
Cancer Hospital, Chinese Academy of Medical Sciences
Start Date
2024-05-01
Trial ID
NCT06254599
Treatments Being Tested
Hypotheses: Short-term - Targeted therapy with erlotinib or crizotinib plu...
Status
Withdrawn
Location
University of Michigan Comprehensive Cancer Center
Start Date
2015-09
Trial ID
NCT02277457
Treatments Being Tested
This is a phase 2 study of a drug called crizotinib in people with metastat...
Status
Completed
Location
Princess Margaret Cancer Centre
Start Date
2019-12-03
Trial ID
NCT04084717
Treatments Being Tested
The purpose of this study is to estimate the effect of multiple doses of Ri...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-07
Trial ID
NCT01147055
Treatments Being Tested
This is a Phase III, Randomized, Open-label, Efficacy and Safety Study of C...
Status
Completed
Location
The First Affiliated Hospital of Anhui Medical University, Department of Medical Oncology
Start Date
2012-09-29
Trial ID
NCT01639001
Treatments Being Tested
This randomized, multicenter, Phase III, open-label study will evaluate the...
Status
Active Not Recruiting
Location
Shanghai Pulmonary Hospital
Start Date
2021-12-31
Trial ID
NCT06569420
Treatments Being Tested
This study is designed to evaluate the potential effect of hepatic impairme...
Status
Completed
Location
Keck Hospital of USC
Start Date
2012-07
Trial ID
NCT01576406
Treatments Being Tested
EUCROSS is a phase II trial to evaluate the efficacy and safety of crizotin...
Status
Completed
Location
Thoraxklinik Heidelberg
Start Date
2014-05
Trial ID
NCT02183870
Treatments Being Tested